Patients Views & Analysis

Views & Analysis

Patients

The rise of prescription drug abuse and drug diversion

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.

Market Access

Nine for 2023, part one: a reflection on inflection

The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one.

Sales & Marketing

Why script-to-dispense conversion will take centre stage in ...

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors.

Oncology

Cancer control in a time of crisis - the pharmaphorum podcas...

During The Economist’s 8th Annual World Cancer Series congress in Brussels November last year, web editor Nicole Raleigh sat down to discuss the event and its themes with

Patients

European Health Data Space (EHDS) update: what this means fo...

The proposed EHDS Regulation1 (Proposal), introduced in May 2022 by the European Commission (EC), aims to reform the “situation of fragmentation” that depicts th

Healthcare